Starcast
Join the waitlist
U.S. Supreme Court Oral Arguments
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
A case in which the Court held that a generic drug manufacturer does not actively induce patent infringement under 35 U.S.C. §271(b) when its communications consist only of legally required labeling, standard industry language, omissions, and vague statements that lack any affirmative purpose of encouraging the patented use.